Lantern Pharma (LTRN) EPS (Basic) (2020 - 2026)
Lantern Pharma's (LTRN) quarterly EPS (Basic) came in at -$0.3 in Q1 2026, up 30.69% YoY from -$0.23 in Q1 2025, and up 21.49% on a QoQ basis from -$0.38 in Q4 2025.
Lantern Pharma (LTRN) EPS (Basic) (2020 - 2026) Analysis & Trends
Lantern Pharma (LTRN) has 7 years of EPS (Basic) data on file, last reported at -$0.3 in Q1 2026.
- Quarterly EPS (Basic) rose 30.69% year-over-year to -$0.3 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.59 (up 18.03% YoY) and the FY2025 annual result came in at -$3.61, up 1.13% from the prior year.
- EPS (Basic) grew to -$0.3 in Q1 2026, from -$0.38 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.26 in Q3 2022 to a low of -$0.57 in Q4 2022.
- A 5-year average of -$0.44 and a median of -$0.43 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2022 — EPS (Basic) tumbled 87.57% — and 2026, when it jumped 30.69%.
- Tracing LTRN's EPS (Basic) over 5 years: stood at -$0.57 in 2022, then climbed by 24.64% to -$0.43 in 2023, then declined by 25.94% to -$0.54 in 2024, then rose by 28.81% to -$0.38 in 2025, then increased by 21.49% to -$0.3 in 2026.
- The last three EPS (Basic) figures came in at -$0.3 (Q1 2026), -$0.38 (Q4 2025), and -$0.54 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.90 Bn | 132.05 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 65.73 Bn | 60.55 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.33 Bn | 53.19 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.72 Bn | 28.42 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.27 Bn | 9.88 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.25 Bn | 26.41 Bn | - | 0.18 |
| 10 | Lantern Pharma | 25.99 Mn | 25.99 Mn | - | -0.30 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.30 |
| Dec 31, 2025 | -0.38 |
| Sep 30, 2025 | -0.54 |
| Jun 30, 2025 | -0.42 |
| Mar 31, 2025 | -0.43 |
| Dec 31, 2024 | -0.54 |
| Sep 30, 2024 | -0.47 |
| Jun 30, 2024 | -0.51 |
| Mar 31, 2024 | -0.52 |
| Dec 31, 2023 | -0.43 |
| Sep 30, 2023 | -0.38 |
| Jun 30, 2023 | -0.55 |
| Mar 31, 2023 | -0.39 |
| Dec 31, 2022 | -0.57 |
| Sep 30, 2022 | -0.26 |
| Jun 30, 2022 | -0.42 |
| Mar 31, 2022 | -0.38 |
| Dec 31, 2021 | -0.65 |
| Sep 30, 2021 | -0.37 |
| Jun 30, 2021 | -0.22 |